longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Eton Pharmaceuticals Director Sold Shares Worth Over $1.6M

TradingView
Jun 17, 2026 at 09:10 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Eton Pharmaceuticals Director Jennifer Mckie Adams sold 50,000 shares of common stock on June 17, 2026, totaling $1,623,795. The weighted average sale price was $32.48 per share. Following this transaction, Adams no longer directly owns any common stock in the company. She authorized another individual to file Form 4 on her behalf.

Jennifer Mckie Adams, a Director, reported a direct sale of common stock on 2026-06-17. The shares were sold in multiple trades at prices ranging from $32.10 to $32.71 with a weighted average sale price of $32.4759 per share. The total sale amount reported was $1,623,795 for 50,000 shares sold. The reporting person no longer directly owns common stock following the reported transaction. The reporting person authorized another named individual to file this Form 4 on her behalf for an indefinite duration.

Reporter NameAdams Jennifer Mckie
RelationshipDirector
TypeSell
Amount$1,623,795
SEC FilingForm 4
Disclaimer
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

Login to unlock302characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Eton Pharmaceuticals

Eton Pharmaceuticals

ETON.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI